2
Symetis and Boston Scientific reach USD 435 million purchase agreement
plus
Actualités sur Health
Shire Pharmaceuticals Group Plc
INTUNIV® (Guanfacine Hydrochloride Prolonged Release), a Non-stimulant for the Treatment of ADHD, Receives Approval in Japan
Zug, Switzerland (ots/PRNewswire) - A New Non-stimulant Clinical Option for Children and Adolescents From 6 to 17 Years old With ADHD Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that its partner in Japan, Shionogi & Co., Ltd, has received the approval of the Japanese Ministry of Health, Labor and Welfare to ...
plusTakeda Pharmaceutical Company Limited
Takeda Announces Appointment of New President of Europe and Canada Business Unit
Zurich (ots/PRNewswire) - Takeda Pharmaceutical Company Limited ("Takeda") announced today that Giles Platford will assume the role of President of the Europe and Canada (EUCAN) Business Unit of Takeda. In this role he will lead business operations in the region effective April 1, 2017. Giles Platford, who joined Takeda in 2009, is also a Corporate Officer and member ...
plusIXALTIS Announces New Data on the Effects of Litoxetine in Models of Urinary Incontinence at the European Congress of Urology (EAU)
Toulouse and Archamps, France (ots/PRNewswire) - Dr. Philippe Lluel from Urosphere, a company specialized in preclinical pharmacology of urogenital tract, presented on behalf of all investigators two scientific posters at the prestigious congress of the European Association of Urology (EAU) in London, showing for ...
plusFiasp®, a new, ultra-fast acting mealtime insulin is available for the treatment of diabetes in adults
Bagsværd, Denmark (ots/PRNewswire) - Canada first country to launch Fiasp® This material is intended for global medical media only. For journalistic assessment and preparation before publication. Today, Novo Nordisk announced that Fiasp®, a new, fast-acting mealtime insulin for the treatment of diabetes in ...
plusFDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for UK-based media - Only FDA-approved treatment for metastatic Merkel cell carcinoma, a rare and aggressive skin cancer - First indication for BAVENCIO, a human anti-PD-L1 antibody Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and ...
plus
La Roche-Posay's My UV Patch Wins the European "Nudging for Good" Diamond Award
Brussels (ots/PRNewswire) - During the "Nudging for Good" Awards Ceremony presented in Brussels, My UV Patch, La Roche-Posay's digital breakthrough innovation to change bad sun habits into life-saving ones, was awarded the Diamond Award by the European Brands Association (AIM). Launched in 2016, the "Nudging for Good" Award aims to honor brands that make it easy and ...
plusShire Pharmaceuticals Group Plc
Shire Receives European Approval for Label Extension of CINRYZE®(C1 inhibitor [human]) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
Zug, Switzerland (ots/PRNewswire) - CINRYZE is now the first and only Hereditary angioedema treatment approved for routine prevention in paediatrics Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the European Commission (EC) has approved a label extension granting three new indications for CINRYZE® (C1 inhibitor ...
plusEuropean Hematology Association (EHA)
EuroBloodNet Aims for Better Care for Patients with Rare Blood Disorders
Vilnius, Lithuania (ots/PRNewswire) - Patients suffering from rare blood disorders will benefit from networks of excellence across the European Member States. At the third conference on European Reference Networks (ERNs) yesterday in Vilnius, Lithuania, EuroBloodNet was officially awarded as one of the recently approved ERNs. ERNs is an initiative of the European ...
plusRoquette Commits to BioPharma Market
Lestrem, France (ots/PRNewswire) - Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries Roquette, a global leader in innovative plant-based pharmaceutical ingredients, announces its commitment to provide new product offerings to address the growing demand for excipients and raw materials for the biopharmaceutical market. (Logo: ...
plusNew Merck Technology Aims to Further Optimize Embryo Incubation and Assessment
Darmstadt, Germany (ots/PRNewswire) - - Merck integrates innovative Eeva® Test with Geri(TM) incubation platform, bringing individualized incubation and outcome prediction together - Geri(TM) humidity technology aims to further advance incubation to precisely monitor and manage the humidity level in the incubator Merck, a leading science and technology company, today ...
plusDSM and Evonik Establish Joint Venture for Omega-3 Fatty Acids From Natural Marine Algae for Animal Nutrition
Kaiseraugst, Switzerland (ots/PRNewswire) - - Breakthrough for animal nutrition to reduce impact on ocean resources and making it more sustainable - Commercial-scale facility for algal oil for salmon aquaculture and pet food to be built in the United States - Further develop and produce a high value algal oil with a ...
plus
Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics
Lausanne (ots) - Change in name reflects new strategy to invest in smart data, therapeutics and diagnostics Debiopharm Diagnostics SA, the strategic investment fund of Debiopharm Group(TM) (www.debiopharm.com), announced its new strategy and the change of name to Debiopharm Innovation Fund SA effective today. With the aim of speeding up innovations that radically ...
plusEuropean Optics Market Records Over EUR17 Billion in 2016
Milan (ots/PRNewswire) - GfK's sales tracking of four key European retail optics markets (Italy, France, Spain and Germany), shows a turnover of EUR17.6 billion for total year 2016. This is a sales value growth of 0.9 percent compared to the previous year. GfK released the findings at the international MIDO 2017 trade fair in Milan. GfK tracks sales data in the optician channel for sunglasses, frames, spectacle lenses, ...
plusLEO Pharma Announces Positive Results From Phase 2b Clinical Study for Tralokinumab in Atopic Dermatitis
Ballerup, Denmark and Orlando, Florida (ots/PRNewswire) - LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD), a serious and chronic form of eczema. Tralokinumab is an investigational ...
plusAccuray Launches New Cancer Patient Websites
Sunnyvale, California (ots/PRNewswire) - The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis, according to the American Cancer Society. Accuray Incorporated (NASDAQ: ARAY) is launching http://www.cyberknife.com and http://www.tomotherapy.com to provide an additional resource for cancer patients to turn to for information about their disease and potential ...
plusPhilips Unveils Access CT at 2017 European Congress of Radiology to Expand CT Capabilities for Cost-conscious Healthcare Organizations
Amsterdam and Vienna (ots/PRNewswire) - - iDose[4] proprietary reconstruction technique lowers operating costs by increasing tube life - iFlow intelligent workflow platform enables consistent image quality from operator-to-operator to reduce rescans Royal Philips (http://www.philips.com/) (NYSE: PHG; AEX: PHIA) ...
plusNICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - More patients now able to receive a standard-of-care treatment with Erbitux plus FOLFIRI or FOLFOX - NICE's recommendation is a significant step forward in Merck's aspiration to ensure cancer patients have optimal access to effective ...
plus
Philips Introduces Advanced Radiology Solutions at 2017 European Congress of Radiology to Address Evolving Healthcare Demands and Support the Changing Role of the Radiologist
Amsterdam and Vienna (ots/PRNewswire) - Royal Philips (http://www.usa.philips.com/) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled new advanced radiology solutions at the 2017 European Congress of Radiology (https://www.myesr.org/ecr-2017) (ECR), beginning March 1 at the Austria Center ...
plusFDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US and UK-based media - Second Biologics License Application accepted by the FDA for avelumab - Prognosis for urothelial carcinoma is currently poor, particularly when the disease has metastasized Merck and Pfizer Inc. today announced that the US ...
plusALK's ACARIZAX® Data Results in Significant Change to the GINA Asthma Management Strategy: Sublingual Allergy Immunotherapy (SLIT) Recommended as a Treatment Option in Patients With House Dust Mite Allergic Asthma
Hørsholm, Denmark (ots/PRNewswire) - ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that for the first time, allergy immunotherapy is now recommended as a treatment option in the Global Initiative for Asthma (GINA) report: Global Strategy for Asthma Management and Prevention. This global strategy is a ...
plusMerck Receives Positive CHMP Opinion for New Pergoveris® Fertility Pen
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. and UK based media - Ready-to-use pre-filled pen provides a convenient treatment option for patients - Simplified injection device for self-administration comes in multiple doses, addressing individual needs of patients Merck, a leading science and technology company, today announced that the European ...
plusShire Pharmaceuticals Group Plc
CHMP Recommends EU Conditional Marketing Authorisation for Natpar® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism
Zug, Switzerland (ots/PRNewswire) - This Press Release is intended for Global Use If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment[1] Shire plc (LSE: SHP, ...
plusTillotts Pharma in Germany Dedicated to Gastrointestinal Health
Berlin (ots/PRNewswire) - Tillotts Pharma is strengthening its presence in the German market: the Berlin office was opened in January 2017 under the management of Magdalena Kritikos. The portfolio includes Entocort® for the treatment of Crohn's disease, Asacol® for the treatment of ulcerative colitis, and VistaPrep® for bowel preparation before endoscopy. With ...
plus
Philips Reinforces Leadership in Image-guided Therapy Solutions with Global Launch of Next Generation Azurion Platform
Amsterdam (ots/PRNewswire) - - Developed in collaboration with leading hospitals worldwide, Philips Azurion (https://www.usa.philips.com/healthcare/resources/landing/azurion) is an innovative image-guided therapy platform that allows clinicians to easily and confidently perform a wide range of routine and complex ...
plusJanssen Announces Two-drug Combination of Dolutegravir and Rilpivirine Demonstrates Efficacy in Maintaining Viral Suppression in Phase III Clinical Studies
Seattle (ots/PRNewswire) - - First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC (Janssen) announced positive results ...
plusCladribine Tablets Significantly Reduced Brain Atrophy in Patients With Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - - Post hoc analysis of Phase III CLARITY study data recently published in Multiple Sclerosis Journal showed statistically significant reduction in brain atrophy in patients on a short course of investigational Cladribine Tablets over two years compared with patients receiving placebo - These findings correlated with effects on ...
plusShire Pharmaceuticals Group Plc
New Data From Shire Aim To Help Close the Diagnosis and Treatment Gap for People With Hemophilia
Zug, Switzerland (ots/PRNewswire) - Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare diseases, presented its new estimate of the Global Annual Bleed Rate (GABR), an effort to build on current global ...
plusFlexible Storage Options can Impact Daily Use of FVIII Treatments in People with Haemophilia A
Paris (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Poster #P024 Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) demonstrated the ...
plusKantar TNS Survey for Nestle Waters on Water Consumption
Paris (ots/PRNewswire) - Water needs is a common ground across populations and cultures according to the survey but local habits and knowledge still affect water consumption Kantar TNS and Nestle Waters published a survey on attitudes about water consumption in seven countries: China, France, Italy, Mexico, the UK, the US and Turkey. To view the Multimedia News Release, please click: ...
plus
Précédent30313233343536373839Suivant